Biote Medical Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
223
- Stock Symbol
-
BTMD
- Investments
-
3
- Share Price
-
$1.06
- (As of Friday Closing)
Biote Medical General Information
Description
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Contact Information
Website
www.biote.comCorporate Office
- 1875 West Walnut Hill Lane
- Suite 100
- Irving, TX 75038
- United States
Corporate Office
- 1875 West Walnut Hill Lane
- Suite 100
- Irving, TX 75038
- United States
Biote Medical Stock Performance
As of 13-Nov-2026, Biote Medical’s stock price is $1.06. Its current market cap is $28.8M with 27M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.06 | $1.03 | $0.99 - $2.90 | $28.8M | 27M | 186K | -$0.07 |
Biote Medical Financials Summary
As of 30-Sep-2026, Biote Medical has a trailing 12-month revenue of $179M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 159,770 | 165,412 | 279,875 | 187,653 |
| Revenue | 178,909 | 192,219 | 197,191 | 185,360 |
| EBITDA | 15,840 | 52,215 | 15,647 | 9,234 |
| Net Income | (1,925) | 27,045 | 3,157 | 3,316 |
| Total Assets | 101,696 | 107,613 | 122,370 | 155,295 |
| Total Debt | 127,825 | 109,922 | 110,862 | 114,871 |
Biote Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biote Medical Comparisons
Industry
Financing
Details
Biote Medical Competitors (1)
One of Biote Medical’s competitors is The SottoPelle Group, a Corporation company based in Scottsdale, AZ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| The SottoPelle Group | Corporation | Scottsdale, AZ |
Biote Medical Signals
Biote Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biote Medical Investments & Acquisitions (3)
Biote Medical’s most recent deal was a Merger/Acquisition with Asteria Health for . The deal was made on 18-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Asteria Health | 18-Mar-2024 | Merger/Acquisition | Pharmaceuticals | ||
| Simpatra (Portfolio of Intellectual Property Rights) | 02-Jan-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Haymaker Acquisition III | 26-May-2022 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Biote Medical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.7 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Facilities
Subindustry
of 117
Rank
Percentile
Biote Medical Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Asteria Health | Birmingham, AL | 2017 |
Biote Medical FAQs
-
When was Biote Medical founded?
Biote Medical was founded in 2012.
-
Where is Biote Medical headquartered?
Biote Medical is headquartered in Irving, TX.
-
What is the size of Biote Medical?
Biote Medical has 223 total employees.
-
What industry is Biote Medical in?
Biote Medical’s primary industry is Pharmaceuticals.
-
Is Biote Medical a private or public company?
Biote Medical is a Public company.
-
What is Biote Medical’s stock symbol?
The ticker symbol for Biote Medical is BTMD.
-
What is the current stock price of Biote Medical?
As of 13-Nov-2026 the stock price of Biote Medical is $1.06.
-
What is the current market cap of Biote Medical?
The current market capitalization of Biote Medical is $28.8M.
-
What is Biote Medical’s current revenue?
The trailing twelve month revenue for Biote Medical is $179M.
-
Who are Biote Medical’s competitors?
The SottoPelle Group is a competitor of Biote Medical.
-
What is Biote Medical’s annual earnings per share (EPS)?
Biote Medical’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process